Production of Plasminogen Activator Inhibitor-1 by Human Mast Cells and Its Possible Role in Asthma1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.165.6.3154PMID 10975829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix degrading metalloproteinases

  2005cited by this paper
• Expression profiling using cDNA microarrays

  1999cited by this paper
• Allergy: Principles and Practice

  1999cited by this paper
• The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis.

  1999influential reference
• Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma.

  1999cited by this paper
• Thrombin in the Airways of Asthmatic Patients

  1999cited by this paper
• The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

  1999cited by this paper
• Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.

  1999cited by this paper
• Expression of plasminogen activator inhibitors type-1 and type-2 in the mouse lung after administration of crystalline silica.

  1998cited by this paper
• Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.

  1998cited by this paper
• Identification and characterization of the inducible murine mast cell gene, imc-415.

  1998cited by this paper
• Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.

  1998cited by this paper
• Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

  1998cited by this paper
• Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells*

  1997cited by this paper
• Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis.

  1997cited by this paper
• Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

  1997cited by this paper
• Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

  1996cited by this paper
• Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

  1996cited by this paper
• Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.

  1996cited by this paper
• Clinical Investigations: Interstitial Lung DiseaseMast Cells in Bronchiolitis Obliterans Organizing Pneumonia: Mast Cell Hyperplasia and Evidence for Extracellular Release of Tryptase

  1996cited by this paper
• Protein C inhibitor (PCI).

  1996cited by this paper
• Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis

  1996cited by this paper
• A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.

  1996cited by this paper
• Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study.

  1995cited by this paper
• Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray

  1995cited by this paper
• Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.

  1995cited by this paper
• Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6.

  1995cited by this paper
• Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.

  1995cited by this paper
• Biological and clinical aspects of plasminogen activator inhibitor type 2.

  1995cited by this paper
• Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.

  1995cited by this paper
• Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model.

  1994cited by this paper
• Matrix metalloproteases and lung disease.

  1994cited by this paper
• Matrix-degrading metalloproteinase

  1994cited by this paper
• Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.

  1994cited by this paper
• Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.

  1994cited by this paper
• Thrombin Stimulates Expression of Tissue-Type Plasminogen Activator and Plasminogen Activator lnhibitor Type 1 in Cultured Human Vascular Smooth Muscle Cells

  1993cited by this paper
• Structural biochemistry and activation of matrix metalloproteases.

  1993cited by this paper
• Plasminogen and Plasminogen Activator Assembly on the Human Endothelial Cell

  1993cited by this paper
• Biology and biochemistry of proteinases in tumor invasion.

  1993cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.

  1993cited by this paper
• Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects.

  1993cited by this paper
• Protein C inhibitor.

  1993cited by this paper
• Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.

  1993cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

  1993cited by this paper
• Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.

  1993cited by this paper
• Basophils and mast cells: piecemeal degranulation in situ and ex vivo: a possible mechanism for cytokine-induced function in disease.

  1992cited by this paper
• The matrix‐degrading metalloproteinases

  1992cited by this paper
• The role of the C-terminal domain in collagenase and stromelysin specificity.

  1992cited by this paper
• Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.

  1992cited by this paper
• Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase.

  1992cited by this paper
• Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.

  1991cited by this paper
• Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.

  1991cited by this paper
• Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.

  1991influential reference
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• [125I]fibrin deposition occurs at both early and late intervals of IgE-dependent or contact sensitivity reactions elicited in mouse skin. Mast cell-dependent augmentation of fibrin deposition at early intervals in combined IgE-dependent and contact sensitivity reactions.

  1990cited by this paper
• Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid.

  1990cited by this paper
• New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity.

  1990cited by this paper
• Matrix metalloproteinases. A review.

  1990cited by this paper
• Mast cells in nonallergic immune responses in vivo.

  1990cited by this paper
• Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.

  1989cited by this paper
• Plasminogen activator release from cultured murine mast cells.

  1988cited by this paper
• Clot Lysis Mediated by Cultured Human Microvascular Endothelial Cells

  1988cited by this paper
• Establishment of an immature mast cell line from a patient with mast cell leukemia.

  1988cited by this paper
• Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.

  1988cited by this paper
• Fibrinolytic System of Vascular Endothelial Cells

  1988cited by this paper
• Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors.

  1988cited by this paper
• Plasminogen activator inhibitors--a review.

  1988cited by this paper
• Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

  1988cited by this paper
• Asbestos-induced fibrosis in rats: increase in lung mast cells and autacoid contents.

  1987cited by this paper
• Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

  1987cited by this paper
• 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.

  1987cited by this paper
• Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.

  1986cited by this paper
• Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor

  1986cited by this paper
• Bioimmunoassay (BIA) of Tissue Plasminogen Activator (t-PA) and Its Specific Inhibitor (t-PA/INH)

  1985cited by this paper
• Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.

  1984cited by this paper
• Sequential expression of new gene programs in inducer T-cell clones.

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Late Phase Allergic Reactions

  1983cited by this paper
• Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.

  1982cited by this paper
• Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages

  1980cited by this paper
• Degradation of connective tissue matrices by macrophages. III. Morphological and biochemical studies on extracellular, pericellular, and intracellular events in matrix proteolysis by macrophages in culture

  1980cited by this paper
• Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.

  1979cited by this paper
• Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation. Ultrastructural and histochemical studies.

  1974cited by this paper
• The mast-cell system : its relationship to atherosclerosis, fibrosis and eosinophils

  1968cited by this paper

• From Chronic Inflammation to Remodeling: Anthocyanins in the Context of Asthma Management.

  2026cites this paper
• Airway Microbiota and Immune Mediator Relationships Differ in Obesity and Asthma.

  2022cites this paper
• High levels of plasminogen activator inhibitor-1, tissue plasminogen activator and fibrinogen in patients with severe COVID-19

  2021cites this paper
• Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients

  2021cites this paper
• Novel therapeutics for hydrocephalus: Insights from animal models

  2021cites this paper
• Proteomic Changes during the Dermal Toxicity Induced by Nemopilema nomurai Jellyfish Venom in HaCaT Human Keratinocyte

  2021cites this paper
• Retinol-binding protein 4 and plasminogen activator inhibitor-1 as potential prognostic biomarkers of non-allergic asthma caused by obesity in adolescents.

  2021cites this paper
• Environmental Disease 5-1-2015 Plasminogen Activator Inhibitor-1 in Cigarette Smoke Exposure and Influenza A Virus Infection-Induced Lung Injury

  2019cites this paper
• Study of the association between obesity, plasminogen activator inhibitor-1, and asthma in preschool children

  2019cites this paper
• Mast cell-derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma.

  2018cites this paper
• Probable Roles of Coagulation Cascade and Fibrinolysis System in the Development of Allergic Rhinitis

  2018cites this paper
• Intraventricular administration of urokinase as a novel therapeutic approach for communicating hydrocephalus

  2017cites this paper
• PAI‐1 gain‐of‐function genotype, factors increasing PAI‐1 levels, and airway obstruction: The GALA II Cohort

  2017cites this paper
• Role of Proteases in Lung Disease: A Brief Overview

  2017cites this paper
• Association between the Promoter -675 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Asthma: An Update of Meta-Analysis

  2017cites this paper
• Mast Cell-Derived PAI-1 Promotes Airway Inflammation and Remodeling in a Murine Model of Asthma*****

  2016cites this paper
• Plasminogen activator inhibitor‐1 does not contribute to the pulmonary pathology induced by acute exposure to ozone

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) Asthma and coagulation : A clinical and pathophysiological evaluation

  2016cites this paper
• The stealthy nano-machine behind mast cell granule size distribution.

  2015cites this paper
• IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators

  2015cites this paper
• N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury.

  2015cites this paper
• Plasminogen Activator Inhibitor-1 in Cigarette Smoke Exposure and Influenza A Virus Infection-Induced Lung Injury

  2015cites this paper
• Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1.

  2015cites this paper
• Epistatic effects of multiple receptor genes on pathophysiology of asthma – its limits and potential for clinical application

  2014cites this paper
• Cross-Talk between Human Mast Cells and Bronchial Epithelial Cells in Plasminogen Activator Inhibitor-1 Production via Transforming Growth Factor- b 1

  2014influential citation
• mast cells and basophils C5a stimulates production of plasminogen activator inhibitor-1 in human

  2013cites this paper
• Production in Lyn-Deficient Mast Cells RI Signaling and to Cytokine and Chemokine ε Increased Expression of Genes Linked to Fc

  2013cites this paper
• Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.

  2013cites this paper
• Impaired fibrinolysis is associated with the severity of aortic stenosis in humans

  2013cites this paper
• Glomerulonephritis Fibrinolytic Activity Protect against Fatal Mast Cell-Mediated Remodeling and

  2013cites this paper
• Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds

  2013cites this paper
• Association of the 4 g/5 g polymorphism of plasminogen activator inhibitor-1 gene with sudden sensorineural hearing loss. A case control study

  2012cites this paper
• Asthma and coagulation.

  2012cites this paper
• Plasminogen Activator Inhibitor-1, Fibrinogen, and Lung Function in Adolescents with Asthma and Obesity

  2012cites this paper
• Obesity, Diet, Exercise and Asthma in Children

  2012cites this paper
• Levels of Components of the Urokinase-Type Plasminogen Activator System are Related to Chronic Obstructive Pulmonary Disease Parenchymal Destruction and Airway Remodelling

  2012cites this paper
• The Expression of Fibrinolytic Components in Chronic Paranasal Sinus Disease

  2011cites this paper
• Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma.

  2011cites this paper
• Unimpeded skin carcinogenesis in K14‐HPV16 transgenic mice deficient for plasminogen activator inhibitor

  2011cites this paper
• SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response

  2011cites this paper
• Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge.

  2011cites this paper
• Adenosine Potentiates Human Lung Mast Cell Tissue Plasminogen Activator Activity

  2011cites this paper
• phosphorylation-mimicking mutant T356d of Annexin Vi, amino- peptidase B, glucose-6-phosphate dehydrogenase, fibrin beta, S-adenosylhomocysteine hydrolase (SAH) (Fig. 1c), actin-related protein 1, NADP-dependent isocitrate dehydrogenase (ICDH) (Fig. 1d), enoyl coA hydratase, and zinc finger protein

  2011influential citation
• Plasminogen activator inhibitor-2 (PAI-2) secreted from activated mast cells induces α-smooth muscle actin (α-SMA) expression in dermal fibroblasts.

  2011cites this paper
• IκB kinase β inhibitor IMD‐0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus‐sensitized mouse model of chronic asthma

  2011cites this paper
• The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma.

  2011cites this paper
• Role of the 4 G / 5 G Polymorphism of Plasminogen Activator Inhibitor-1 Gene in Idiopathic Sudden Sensorineural Hearing Loss , A Case Control Study

  2011cites this paper
• The Blood Urokinase System in Patients with Seasonal Allergic Rhinitis and Concomitant Seasonal Asthma during Pollen Season

  2011cites this paper
• Inhibition of Plasminogen Activator Inhibitor-1 Expression in Smoke-Exposed Alveolar Type II Epithelial Cells Attenuates Epithelial-Mesenchymal Transition

  2011cites this paper
• Plasminogen activation by airway smooth muscle is regulated by type I collagen.

  2011cites this paper
• Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy

  2010cites this paper
• This information is current as Cell Tissue Plasminogen Activator Activity Adenosine Potentiates Human Lung Mast

  2010cites this paper
• Up-regulation of the Extrinsic Coagulation Pathway in Acute Asthma—A Case Study

  2010influential citation
• Developmental Factors of Fibrous Opacification in the Atopic Cataract Lens Capsule

  2010cites this paper
• Cyclic adenosine monophosphate induces plasminogen activator inhibitor-1 expression in human mast cells.

  2010cites this paper
• Mast Cell-Specific Genes as New Drug Targets

  2010cites this paper
• Advances in mast cell biology: new understanding of heterogeneity and function

  2010cites this paper
• Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.

  2009cites this paper
• Remodeling of the lower and upper airways Summary

  2009cites this paper
• Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism in Turkish Adult Patients with Asthma

  2009cites this paper
• Plasminogen activator inhibitor‐1 and asthma: role in the pathogenesis and molecular regulation

  2009cites this paper
• PLASMINOGEN ACTIVATOR INHIBITOR-1 PROMOTES INFLAMMATORY PROCESS INDUCED BY CIGARETTE SMOKE EXTRACTION OR LIPOPOLYSACCHARIDES IN ALVEOLAR EPITHELIAL CELLS

  2009cites this paper
• Remodelamento das vias aéreas inferiores e superiores

  2009cites this paper
• Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model.

  2009cites this paper
• Remodeling of the lower and upper airways.

  2009cites this paper
• A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice.

  2009cites this paper
• Progress in allergy signal research on mast cells: systemic approach to mast cell biology in allergic diseases.

  2008cites this paper
• Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients.

  2008cites this paper
• Plasmin System Regulation in an Ovalbumin-Induced Rat Model of Asthma

  2008cites this paper
• Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor‐1

  2008cites this paper
• Étude d'association entre l'asthme et le gène plasminogen activator, urokinase dans la population du Saguenay-Lac-Saint-Jean

  2008cites this paper
• Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.

  2008cites this paper
• Gene expression patterns in asthma

  2008cites this paper
• Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis

  2008influential citation
• Analysis of the coagulation cascade and fibrinolysis system components in allergic rhinitis murine model

  2008cites this paper
• Plasminogen Activator Inhibitor-1 Plasma Concentration in Allergic Asthma Patients during Allergen Challenge

  2007cites this paper
• IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice.

  2007cites this paper
• The plasminogen activation system in lung disease.

  2007cites this paper
• Upstream stimulating factor‐1 mediates the E‐box‐dependent transcriptional repression of the plasminogen activator inhibitor‐1 gene in human mast cells

  2007cites this paper
• Coagulation factor Xa modulates airway remodeling in a murine model of asthma.

  2007cites this paper
• Characterisation of gene expression in the airway epithelium of children with asthma

  2007cites this paper
• The human mast cell: an overview.

  2006cites this paper
• Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis1

  2006cites this paper
• Airway remodelling in asthma: current understanding and implications for future therapies.

  2006cites this paper
• Response to Comment on “Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis”

  2006cites this paper
• Mast cell‐mediated airway remodelling

  2006cites this paper
• Microarray-based identification of novel biomarkers in asthma.

  2006cites this paper
• The −675 4G/5G plasminogen activator inhibitor‐1 promoter polymorphism in house dust mite‐sensitive allergic asthma patients

  2006cites this paper
• Serine proteases, their inhibitors and allergy

  2006cites this paper
• Genetic polymorphisms at FCER1B and PAI‐1 and asthma susceptibility

  2006cites this paper
• COAGULATION CASCADE | iuPA, tPA, uPAR

  2006cites this paper
• Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.

  2006cites this paper
• Platelet Function and Fibrinolytic Activity in Patients with Bronchial Asthma

  2005cites this paper
• Rapidly changing perspectives about mast cells at mucosal surfaces

  2005cites this paper
• Increased Expression of Genes Linked to FcεRI Signaling and to Cytokine and Chemokine Production in Lyn-Deficient Mast Cells1

  2005cites this paper
• Epithelium, heal thyself !

  2005cites this paper
• Mast cell mediators in airway remodeling.

  2005cites this paper
• Airway remodeling contributes to the progressive loss of lung function in asthma: an overview.

  2005cites this paper
• Untersuchungen zur Bedeutung mesenchymaler Stammzellen in der Geweberegeneration

  2005cites this paper
• 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.

  2005cites this paper